Albany, USA – DelveInsight has released its recent report, “Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast-2032,” providing a comprehensive exploration of the evolving treatment landscape for Parkinson’s disease. This extensive study covers historical and forecasted epidemiology, market trends, and emerging therapeutic interventions across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Link to Report: Parkinson’s Disease Market
Key Highlights from the Parkinson’s Disease Market Report:
- Robust Growth: DelveInsight projects a substantial Compound Annual Growth Rate (CAGR) for the Parkinson’s disease market by 2032, indicating promising growth.
- Market Size Milestone: In 2022, the Parkinson’s disease market in the 7 Major Markets (7MM) achieved a significant milestone, reaching approximately USD 3.2 billion, setting the stage for dynamic developments throughout the forecast period.
- Industry Pioneers: Major players leading the charge in Parkinson’s disease research and treatment include Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, Annovis Bio, Amneal Pharmaceuticals, BioVie, Cerevance, Clene Nanomedicine, Intra-Cellular Therapies, Hoffmann-La Roche, Prothena Corporation, among others.
- Upcoming Therapies: The report highlights anticipated therapeutic launches, such as Tavapadon, P2B001, ABBV-951 (foscarbidopa/foslevodopa), BIIB122/DNL151, Buntanetap, IPX203, NE3107, CVN424, CNM-Au8, ITI-214 (lenrispodun), Prasinezumab (RO7046015/RG7935/PRX002), and more.
Parkinson’s Disease Overview:
Characterized by the degeneration of nerve cells in the substantia nigra region of the brain, Parkinson’s disease significantly impacts motor functions. While the precise cause remains elusive, environmental risk factors and genetic predisposition are hypothesized contributors. The majority of cases are sporadic, with up to 20% of individuals having a first-degree relative with the disease.
Parkinson’s Disease Market Analysis:
DelveInsight’s report delves into historical, current, and projected market trends, analyzing the impact of existing therapies, unmet needs, market drivers, barriers, and the demand for advanced technology. Comprehensive insights into each marketed drug and late-stage pipeline therapy are provided, evaluating factors such as the annual cost of therapy, mechanism of action, compliance rates, patient segments, and expected launch year.
Link to Report: Parkinson’s Disease Market Size
Parkinson’s Disease Epidemiological Insights:
The epidemiology section offers a nuanced understanding of historical and current patient pools for Parkinson’s disease across seven major countries. It explores trends through segmentation based on diagnosed prevalent populations, gender, age, and disease stage.
Parkinson’s Disease Drugs Uptake and Pipeline Development:
The report scrutinizes the uptake rate of potential Parkinson’s disease drugs recently launched or expected between 2019-2032. It covers market uptake, patient uptake, and sales for each drug, aiding in understanding factors influencing market share and size. The pipeline analysis assesses therapeutic candidates in Phase II and Phase III stages, with a focus on key players driving targeted therapeutic development.
Parkinson’s Disease Therapeutics Assessment:
Major companies actively contribute to the Parkinson’s disease therapeutics market, developing novel therapies expected to shape treatment approaches in the coming years. Key players include Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, Annovis Bio, Amneal Pharmaceuticals, BioVie, Cerevance, Clene Nanomedicine, Intra-Cellular Therapies, Hoffmann-La Roche, Prothena Corporation, and others.
Report Key Insights:
- Parkinson’s Disease Patient Population
- Parkinson’s Disease Market Size and Trends
- Key Cross Competition in the Parkinson’s Disease Market
- Parkinson’s Disease Market Dynamics (Key Drivers and Barriers)
- Parkinson’s Disease Market Opportunities
- Parkinson’s Disease Therapeutic Approaches
- Parkinson’s Disease Pipeline Analysis
- Parkinson’s Disease Current Treatment Practices/Algorithm
- Impact of Emerging Therapies on the Parkinson’s Disease Market
For a comprehensive understanding of the Parkinson’s Disease Market report, including the detailed table of contents and key insights, visit: Parkinson’s Disease Market
Trending Reports:
- Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
- Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
- Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
- Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
- Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
- Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
- Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
- Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
- Scleroderma Market: https://www.delveinsight.com/report-store/scleroderma-market
- Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
- Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
- Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
- Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
- Eczema Market: https://www.delveinsight.com/report-store/eczema-market
- Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
- Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
- Bone Grafts And Substitutes Market: https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market
- Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
DelveInsights multidimensional, purposeful, and credible pharma and medtech consulting services will aid in the acceleration of product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several market challenges.
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
+91-9650213330
Healthcarewriter 
Leave a comment